1. Results of Searches and Screening of Potentially Relevant Studies
Patricia McGettigan, and David Henry. JAMA 2006;296:

2. Details of the Case-Control Studies Included in the Meta-analysis - Part I
Patricia McGettigan, and David Henry. JAMA 2006;296:

3. Details of the Case-Control Studies Included in the Meta-analysis - Part II
Patricia McGettigan, and David Henry. JAMA 2006;296:

4. Details of the Cohort Studies Included in the Meta-analysis
Patricia McGettigan, and David Henry. JAMA 2006;296:

5. Results of Case-Control and Cohort Studies Reporting on Cardiovascular Risks With Cyclooxygenase 2 Inhibitors
Patricia McGettigan, and David Henry. JAMA 2006;296:

6. Results of Case-Control and Cohort Studies Reporting on Cardiovascular Risks With Nonselective NSAIDs
Patricia McGettigan, and David Henry. JAMA 2006;296:

7. Point Estimates and Summary Relative Risks for Cardiovascular Events With Rofecoxib and Celecoxib
Patricia McGettigan, and David Henry. JAMA 2006;296:

8. Point Estimates and Summary Relative Risks for Cardiovascular Events With Naproxen and Diclofenac
Patricia McGettigan, and David Henry. JAMA 2006;296: